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Identification of a Fetal Hematopoietic
Precursor with B Cell, T Cell,
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However, with the identification of new cytokines, im-
provements in culture methods, and progress in cell
separation techniques, significant advances in the isola-
tion of novel lymphoid precursor populations have been
made in recent years.
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One important finding in this regard was the identifi-²Department of Microbiology
cation by Cumano et al. (1992) of a B cell/macrophage-University of Umea
restricted precursor in the AA4.11/Sca-11/B2202/Mac-12Umea 90187
subpopulation of fetal liver. Although a number of earlierSweden
studies with immortalized lymphoid cell lines (Davidson³Department of Immunology
et al., 1988; Borzillo et al., 1990; Principato et al., 1990)University of Colorado
and transgenic mice (Klinken et al., 1988) suggested aHealth Sciences Center
close relationship between these lineages, the isolationDenver, Colorado 80262
of these bipotential precursors from fetal liver formally
documented this unexpected myeloid/lymphoid branch-
point within the hematopoietic system. To date, T cell
Summary developmental potential has not been associated with
this precursor. More recently, Kawamoto et al. (1997)
Despite years of investigation, precursor-progeny re- provided further evidence for lymphoid and myeloid lin-
lationships within the developing lymphoid lineages of eage combinations within the fetal lymphoid system.
the hematopoietic system remain poorly defined. We Analysis of the developmental potential of single Sca-11
have characterized the potential of precursors found fetal liver cells indicated the presence of restricted B
within a subpopulation of fetal liver defined by AA4.1 cell/myeloid, T cell/myeloid, as well as multipotential B
and FcgRII/III expression and predominantly restricted cell/T cell/myeloid precursors. Precursors with re-
to lymphoid and macrophage development. When cul- stricted B cell/T cell developmental potential were not
tured in methylcellulose with appropriate cytokines, identified in this analysis. Together, the studies on fetal
AA4.11/FcgR1 precursors generate colonies consisting liver suggest that the B and possibly the T cell lineages
of various lineages, including the combination of B cell, develop through intermediates that share a close rela-
T cell, and macrophage. Retroviral marking studies tionship with the macrophage and possibly other mye-
showed that the lymphoid cells and macrophages loid lineages.
within these colonies arise from a common precursor. Further insights into lymphoid lineage relationships
These results demonstrate the presence of a com- have been provided by the analysis of subpopulations
mon precursor with B cell-, T cell-, and macrophage- of fetal and adult thymocytes. Although the large major-
restricted potential and as such define an early restric- ity of cells within the thymus are of the T lineage, a
tion point within the fetal lymphoid system. number of different studies have demonstrated the pres-
ence of precursors from other lineages. For instance, at
12±14 days of gestation, the fetal thymus contains BIntroduction
cell, macrophage, and natural killer (NK) cell precursors
in addition to those of the T lineage (Rodewald et al.,The myeloid, erythroid, and lymphoid lineages of the
1992; Peault et al., 1994; Hattori et al., 1996; Carlyle ethematopoietic system develop from multipotential stem
al., 1997). Studies on the adult thymus have identifiedcells through intermediate stage precursors that display
populations that contain combinations of B cell, T cell,various restricted patterns of commitment (Keller, 1992;
NK cell, and dendritic cell (DC) precursors (Wu et al.,Morrison et al., 1995). This pool of precursors represents
1991; Ardavin et al., 1993; Godfrey and Zlotnik, 1993;a continuum that spans the entire developmental spec-
Matsuzaki et al., 1993; Moore and Zlotnik, 1995; Wu ettrum from immature multipotential cells to relatively ma-
al., 1996). Erythroid and myeloid precursors were notture lineage-restricted populations. Many of these pre-
detected in these populations. The presence of thesecursors have been defined through the use of sensitive
different lineages within the thymus has led to the specu-in vitro clonal assays that were initially established and
lation that they develop from a common precursor, pos-optimized for the growth of erythroid and myeloid cells
sibly the cell that seeds the organ in both fetal and adult(Metcalf, 1977). Consequently, our understanding of the
life. While this interpretation is consistent with theseintermediate stages of development of these lineages is
findings, only the T cell and NK cell lineages have beenreasonably well advanced. In contrast, culture systems
linked to a common precursor by clonal analysis (San-that promote the growth of B and T cell precursors have
chez et al., 1994). The relationship of these other lin-only recently been developed, and therefore the earliest
eages within the thymus remains to be determined.stages of lymphopoiesis are not nearly as well defined
A somewhat clearer picture of the relationship be-as the early stages of myelopoiesis and erythropoiesis.
tween the NK, DC, and lymphoid lineages has begun to
emerge from detailed analysis of human and mouse
bone marrow subpopulations. Within the human hema-§ To whom correspondence should be addressed (e-mail: kellerg@
njc.org). topoietic system, Galy et al. (1995) identified a CD341/
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Figure 1. Characterization of the Myeloid/Erythroid and Lymphoid Potential of Day 13 Fetal Liver AA4.11/FcgR2 and AA4.11/FcgR1 Cells
(A) Representative FACS staining profile of fetal liver cells showing both the AA4.11/FcgR2 and AA4.11/FcgR1 populations. (B) Myeloid and
erythroid precursor content of the AA4.11/FcgR2 and AA4.11/FcgR1 fractions. (C) Repopulation of fetal thymi in organ culture (FTOC) with
freshly isolated day 13 fetal liver fractions. Host thymi express Thy 1.1., and fetal liver donor cells express Thy 1.2. Numbers in quadrants
refer to the percentage of cells gated. (D) IgH rearrangements of fractionated fetal liver cells cultured on S-17 stromal cells in the presence
of IL-7 for 2 weeks. The types of colonies scored are as follows: NEUT, neutrophil colonies; MAST, mast cell colonies; MIX, mixed colonies
(i.e., colonies with an erythroid component plus at least two other lineages); MAC, macrophage colonies; ERY, erythroid colonies. Bars
represent standard error of the mean of colony counts from 14 cultures. Absence of bars indicates that the error is too small to be visualized.
FL represents day 13 total fetal liver, -Ve represents PCR reagents with no cells, and S-17 stromal cells (S-17) were used as the negative
control.
CD101 fraction of bone marrow that contained a precur- and contains lymphoid and macrophage but few my-
eloid and erythroid precursors. By clonal analysis, wesor with restricted B cell, NK cell, and DC potential.
Whether or not this precursor also has T cell potential have identified a fetal AA4.11/FcgR1 precursor with re-
stricted B cell, T cell, and macrophage developmentalis unclear. In a more recent study, Kondo et al. (1997)
identified a mouse bone marrow population that ex- potential. Given its potential, this precursor defines an
early commitment step within the fetal hematopoieticpresses the IL-7 receptor, low levels of Ly6A (Sca-1)
and c-kit, and no detectable levels of lineage-specific system, one that is likely intermediate between the multi-
potential stem cell and the previously identified B/MACmarkers. Functional analysis of this population demon-
strated that it has B, T, and NK precursor activity but precursor.
no detectable myeloid or erythroid potential. Limiting
dilution studies indicated that some of the precursors Results
within this population have both B and T cell potential,
suggesting that a common lymphoid B/T precursor may Myeloid and Lymphoid Potential of Day 13
Fetal Liver Subpopulationsexist in the bone marrow of the mouse.
Collectively, these studies have demonstrated the ex- To study early steps of lymphoid commitment and to
access early precursors, we focused our analysis on theistence of several new lymphoid precursors and have
provided evidence that suggests that others do exist. onset of lymphopoiesis in the developing fetal liver. We
have previously shown that day 12 fetal liver can beIn addition, they have revealed several differences be-
tween lymphoid development in the adult and the fetus. fractionated into distinct populations of lymphoid and
myeloid precursors on the basis of expression of AA4.1To further define the earliest stages of fetal lymphoid
development, we have characterized a subpopulation and the low-affinity Fc receptors, FcgRII/III (Carlsson et
al., 1995). In the present series of experiments, we haveof fetal liver that expresses both AA4.1 and FcgRII/III
B/T/MAC-Restricted Fetal Precursor
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extended the analysis to day 13 of gestation as the liver donor-derived (H-2Kb) IgM1 B cells in the peritoneal cav-
ity and spleen and donor-derived CD31 T cells in thecontains significantly more cells than at day 12 but is
thymus (Figure 2A). In contrast to the lymphoid repopu-still representative of early development. At day 12 of
lation, striking differences in the myeloid/erythroid re-gestation, we found that only the fractions that ex-
population of the bone marrow of the two sets of micepressed the AA4.1 marker, the AA4.11/FcgR2 (hereafter
were observed. Animals transplanted with the AA4.11referred to simply as AA4.11) and the AA4.11/FcgR1
population contained significant numbers of myeloidfractions, contained lymphoid precursors. Consequently,
(Mac-11 and Gr-11) and erythroid (TER-1191) donor-we have focused our efforts on the comparable fractions
derived cells in the marrow, demonstrating completein day 13 fetal liver in this study. Figure 1A demonstrates
multilineage repopulation. In contrast, mice transplantedthat day 13 fetal liver contained the two expected AA4.11
with AA4.11/FcgR1 cells did not contain significant lev-fractions, each representing approximately 2%±4% of
els (above background) of donor myeloid and erythroidthe total nucleated cell population.
cells in the marrow, suggesting that, at this time point,The myeloid and erythroid potential of these two frac-
reconstitution was primarily restricted to the lymphoidtions was analyzed by colony growth in methylcellulose
lineages. These findings are consistent with the in vitroin the presence of a broad spectrum of hematopoietic
analysis and further support the interpretation that thecytokines. The AA4.11 fraction was enriched for precur-
AA4.11/FcgR1 fraction contains mostly lymphoid pre-sors of multiple lineages, including neutrophil, mast cell,
cursors but is devoid of intermediate-stage erythroidmultipotential (mix), macrophage, and erythroid (Figure
and myeloid precursors with the exception of those of1B), as observed previously with the comparable frac-
the macrophage lineage. At week 14 of repopulation,tion from day 12 fetal liver (Carlsson et al., 1995). In
mice transplanted with either AA4.11 or AA4.11/FcgR1contrast, the AA4.11/FcgR1 subpopulation contained
cells again showed good lymphoid repopulation in allrelatively few clonable precursors and those that were
tissues analyzed. Analysis of the bone marrow compart-detected were predominantly restricted to the macro-
ments of mice transplanted with AA4.11/FcgR1 cellsphage lineage. Occasionally a few erythroid, mast, and
indicated that they now contained detectable donormix precursors were detected but their frequency was
Mac-11, Gr-11, and TER-1191 cells. Mice transplantedalways low, often less than 1 per 5,000 cells. Analysis
with AA4.11 cells continued to show almost completeof the day 9 CFU-S content of the two fractions con-
marrow repopulation at this time point. The analysis offirmed the findings from the in vitro colony assay. The
these long-term transplanted mice suggests that the
AA4.11 population gave rise to an average of 27 spleen
AA4.11/FcgR1 fraction does contain some stem cells
colonies (27.5 6 2) per 2 3 104 cells injected, whereas
that require more than 4 weeks to contribute significantly
the same number of AA4.11/FcgR1 cells generated an to the repopulation of these animals.
average of less than one colony (0.7 6 0.5) per mouse. While the above study showed little myeloid/erythroid
Unfractionated fetal liver gave rise to 27 CFU-S (27.3 6 potential of the AA4.11/FcgR1 population 4 weeks post
2.5) per 105 cells, and uninjected controls contained no transplantation, it is possible that this fraction contained
spleen colonies. more mature precursors that provided an early transient
Lymphoid analysis demonstrated that both the AA4.11 wave of repopulation. To investigate this possibility, the
and the AA4.11/FcgR1 fractions contained T cell precur- peripheral blood of mice transplanted with 1.5 3 104
sors that generated both ab and gd T cells in fetal thymi AA4.11 or AA4.11/FcgR1cells was analyzed within the
organ culture (FTOC, Figure 1C). Maturation of the lin- first 4 weeks following cell injection. As shown in Figure
eages from these precursors appeared normal as dem- 2B, mice transplanted with AA4.11 cells did contain
onstrated by the development of both CD41CD82 and significant levels of donor-derived IgM1, Mac-11 and
CD42CD81 T cells. When cultured on irradiated S-17 TER-1191 cells in peripheral blood at 2 weeks following
stromal cells in the presence of IL-7, cells from both transplantation. In contrast, mice transplanted with the
fractions generated characteristic cobblestone areas AA4.11/FcgR1 fraction showed no repopulation in the
that gave rise to B lymphocytes displaying both DJH and peripheral blood at this time point (Figure 2B). After
VDJH immunoglobulin heavy chain gene rearrangements 6 weeks of reconstitution, the repopulation pattern of
(Figure 1D). Together, these data demonstrate that the animals transplanted with these two populations was
AA4.11/FcgR1 subpopulation from day 13 fetal liver con- almost identical to that observed in the recipients in the
tains B cell, T cell, and macrophage precursors but is experiments described in Figure 2A. Mice transplanted
depleted of precursors from the erythroid and other my- with AA4.11 cells showed multilineage repopulation,
eloid lineages. In contrast, the AA4.11 fraction contains while those that received AA4.11/FcgR1 cells showed
erythroid and multiple myeloid precursors in addition to predominantly lymphoid repopulation.
those of the B cell and T cell lineages. Taken together, the findings from the repopulation
experiments are consistent with the interpretation that
Repopulating Potential of the AA4.11 and the AA4.11 fraction of fetal liver contains a broad spec-
AA4.11/FcgR1 Fetal Liver Fractions trum of precursors ranging from multipotential stem cells
To further evaluate the developmental potential of these to relatively later precursors that provide rapid repopula-
fractions, varying numbers of cells from each were trans- tion. In contrast, the AA4.11/FcgR1 fraction is enriched
planted into irradiated SCID mice. Animals repopulated for B and T lymphoid precursors relative to myeloid and
with 2 3 104 cells were analyzed at 4 weeks, while those erythroid precursors and multipotential stem cells and
that received 8 3 103 cells were sacrificed and analyzed as such represents an ideal population for the identifica-
14 weeks following transplantation. At 4 weeks of repop- tion of possible novel precursors representing early
stages of lymphoid development.ulation, mice transplanted with either fraction contained
Immunity
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Figure 2. Analysis of SCID Mice Repopulated with Day 13 Fetal Liver AA4.11/FcgR2 and AA4.11/FcgR1 Cells
(A) Analysis of repopulation of SCID mice transplanted with varying numbers of AA4.11/FcgR2 and AA4.11/FcgR1 fetal liver cells. Animals
transplanted with 2 3 104 cells were analyzed at 4 weeks, while those that received 8 3 103 cells were analyzed at 14 weeks following
transplantation. Cells from peritoneal cavity, spleen, thymus, and bone marrow cells were stained with antibodies directed against H-2Kb or
H-2Kd (data not shown) and different lineage markers. Donor C57BL/6 fetal liver cells express H-2Kb MHC, whereas the SCID recipients express
H-2Kd. (B) Analysis of peripheral blood and (C) spleen, thymus, and bone marrow of SCID mice transplanted with 1.5 3 104 AA4.11/FcgR2
and AA4.11/FcgR1 fetal liver cells. Background staining in SCID mice is as follows: 0.2 6 0.1% for H2Kb/IgM, 0.5 6 0.3% for H2Kb/Mac-1,
0.3 6 0.1% for H2Kb/Gr-1, and 0.8 6 0.1% for H2Kb/TER-119 in peripheral blood, 0.8 6 0.7% for H2Kb/IgM in spleen, 1 6 0.3% for H2Kb/CD3
in thymus, 1.4 6 0.6% for H2Kb/Mac-1, 0.9 6 0.1% for H2Kb/Gr-1, and 0.9 6 0.2% for H2Kb/TER-119 in bone marrow.
Colony Formation by d13 Fetal Liver cultures of AA4.11 cells. However, given the large num-
bers of other types of colonies in these cultures, theirAA4.11/FcgR1 Precursors
To define the clonogenic potential of the lymphoid pre- identification was difficult. Thus, most of the following
analysis was done on colonies generated from AA4.11/cursors in this fraction, AA4.11/FcgR1 cells were cul-
tured in methylcellulose in the presence of irradiated FcgR1 precursors. To define the lymphoid potential of
these cells, colonies were picked from the methylcellu-S-17 stromal cells and recombinant IL-7, conditions
known to support the growth of lymphoid precursors in lose cultures, pooled, and assayed for the presence of
B cell precursors on S-17 stromal cells with IL-7 and forculture (Cumano et al., 1992). Under these conditions,
macrophage colonies developed within the first 3±4 T cell precursors in FTOC. As shown in Figure 3C, the
cells from pooled colonies did give rise to B cells show-days of culture. Following an additional 3±4 days, a small
proportion of these macrophage colonies showed fur- ing DJH rearrangements and to both ab and gd T cells
in the repopulated thymi.ther development, characterized by the outgrowth of
small cells with a lymphoid morphology (Figures 3A and In an effort to promote the development of all possible
lineages within the colonies, S-17/IL-7 cultures were3B). These colonies continued to grow over a 10±14 day
culture period, reaching macroscopic sizes of greater supplemented with interleukin-11 (IL-11), c-Kit ligand
(KL), erythropoietin (Epo), and leptin. IL-11 and KL werethan 105 cells. Similar colonies could be detected in
B/T/MAC-Restricted Fetal Precursor
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Figure 3. Morphology and Growth Factor Requirements of Myeloid/Lymphoid Colonies Generated from AA4.11/FcgR1 Cells
(A) Morphology of a myeloid/lymphoid colony (original magnification 403). (B) May-Grunwald Giemsa staining of the cells from a myeloid/
lymphoid colony (original magnification 10003). Cells with macrophage (M) and lymphoid (L) morphologies are indicated. (C) Analysis of the
lymphoid potential of a pool of myeloid/lymphoid colonies grown in IL-7/S-17 conditions. FACS analysis of fetal thymi repopulated with cells
from pooled colonies and DJH rearrangements of S-17 cultures of pooled colonies (Pool) and fresh fetal liver (FL) cells. (D) Frequency of
macrophage (MAC) and myeloid/lymphoid colonies (MYE/LYMP) generated in different combinations of growth factors. Standard errors of
the mean of the colony counts of 10 cultures are included but not visible in most cases.
included to support the development of early hemato- multiple lineages able to generate secondary colonies,
entire dishes were harvested and replated in secondarypoietic precursors. In addition, previous studies have
shown that these cytokines together with IL-7 promote methylcellulose cultures. The equivalent of an entire pri-
mary culture established with 1500 AA4.11 cells replatedthe development of myeloid/lymphoid colonies, includ-
ing the B cell/macrophage precursor (Hirayama and on day 13 of culture generated an average of 200 neutro-
phil, 80 megakaryocyte, 1600 mast cell, 680 macro-Ogawa, 1994; Kee et al., 1994; Ball et al., 1995). Leptin
was tested, as recent studies have suggested that it phage, and 450 erythroid secondary colonies. Together,
these findings clearly demonstrate that these conditionscould play a role in lymphopoiesis (Baumann et al., 1996;
Bennett et al., 1996; Cioffi et al., 1996; Gainsford et al., do support the development of the erythroid and multi-
ple myeloid lineages.1996). Epo was included to promote the differentiation
of potential erythroid precursors within the colonies. To In the presence of IL-7, KL, IL-11, Epo, Leptin, and S-17,
the myeloid/erythroid potential of the AA4.11/FcgR1determine if these cytokines together with S-17 stromal
cells do indeed support the development of both the fraction was identical to that observed in the previous
analysis (Figure 1B), further confirming that this popula-myeloid and erythroid lineages, they were tested on
the AA4.11 fraction. We used this fraction as a test tion was predominantly restricted to macrophage and
lymphoid development. The number of myeloid/lymphoidpopulation as it contains precursors for multiple lin-
eages. From 5000 cells plated, the combination of IL-7, colonies, generated from the AA4.11/FcgR1 fraction, did
not change dramatically with the addition of IL-11, KL,KL, IL-11, Epo, Leptin, and S-17 supported the develop-
ment of 21 mast cell, 468 macrophage, 43 erythroid, and Epo, and leptin to S-17 and IL-7, and their development
was still dependent on the presence of S-17 cells (Figure30 multilineage colonies. In comparison, the myeloid/
erythroid mix, used in our initial analysis (Figure 1B), 3D). The additional cytokines did, however, promote the
development of lineages other than macrophage andsupported the development of 11 mast, 470 macro-
phage, 45 erythroid, and 20 multilineage colonies in this lymphoid in some of the myeloid/lymphoid colonies.
Based on morphological assessment, approximatelyexperiment. To also determine if these conditions sup-
port the development and maintenance of precursors of 10%±15% of these colonies were found to contain cells
Immunity
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Table 1. Developmental Potential of Myeloid/Lymphoid Colonies
Potential of Colonies Combination of Growth Factors
IL-7, S-17 IL-7, KL, IL-11 IL-7, KL, IL-11, Epo
(37) Epo, S-17 (39) Leptin, S-17 (29)
B/T/MAC/MAST/ERY 0% (0) 0% (0)* 14% (4)*
B/T/MAC 13% (5) 10% (4)* 45% (13)*
B/MAC 11% (4) 23% (9) 27% (8)
B 76% (28) 67% (26)* 14% (4)*
The combination of growth factors used and the total number of colonies with lymphoid potential detected (parentheses) are indicated in the
column heading. Data are presented as percentage of lymphoid colonies with a given potential, and the corresponding number of colonies
is indicated in parentheses. B, B cell; T, T cell; MAC, macrophage; MAST, mast cell; ERY, erythroid. Statistically significant differences (p ,
0.05, Fisher Exact Test) in frequency of colonies with a given developmental potential generated in IL-7, KL, IL-11, Epo, and S-17 or IL-7, KL,
IL-11, Epo, Leptin, and S-17 conditions are indicated by an asterisk.
of the erythroid, neutrophil, and mast cell lineages fol- had no effect on the frequency of colonies that con-
tained B, T, and MAC precursors. With the addition oflowing more than 12 days of culture. Thus, under appro-
priate conditions, three major types of colonies were leptin to this combination of cytokines, the potential of
the colonies changed dramatically. Almost half of thegenerated from the AA4.11/FcgR1 cells; those con-
sisting of pure macrophages, those containing macro- myeloid/lymphoid colonies were found to contain B cell,
T cell, and macrophage precursors (45%). Furthermore,phage and lymphoid cells, and those with a broader
spectrum of lineage cells, including erythroid, neutro- 14% of the colonies generated under these conditions
contained erythroid, mast, and macrophage precursorsphil, mast cell, macrophage, and lymphoid.
in addition to those of the B cell and T cell lymphoid
lineages (B/T/MAC/MAST/ERY). This frequency is inB Cell, T Cell, and Myeloid/Erythroid Potential
of Individual Colonies agreement with the previous morphological analysis,
which indicated that approximately 10%±15% of my-To determine if B and T cell precursors resided within
the same colony, individual myeloid/lymphoid colonies eloid/lymphoid colonies generated under these condi-
tions contained erythroid and multiple myeloid lineages.were picked and assayed as early as they could be
distinguished from pure macrophage colonies (day 8±10 Finally, in the presence of leptin, the proportion of colo-
nies displaying only B cell precursor potential was signif-of culture). All of the colonies assayed had a visible
macrophage component. Individual early colonies were icantly reduced. Representative results demonstrating
the presence of B and T cell precursors in a B/T/MAC/fractionated and cells were tested for their ability to
reconstitute FTOC, to give rise to B cells when seeded MAST/ERY colony (colony 15) and in a B/T/MAC colony
(colony 16) are shown in Figures 4A and 4B. Taken to-on S-17 in the presence of IL-7, and to grow and differen-
tiate as myeloid/erythroid colonies in methylcellulose. gether, these findings demonstrate that leptin, in combi-
nation with IL-7, KL, IL-11, Epo, and S-17, supports theOut of 41 single colonies analyzed from IL-7- and S-17-
stimulated cultures, 37 contained lymphoid precursors, efficient development of myeloid, erythroid, and espe-
cially T cell precursors within the colonies. The fact thatwhereas the remaining 4 showed no precursor activity
or displayed only myeloid/erythroid potential. As shown all types of colonies, B/T/MAC/MAST/ERY, B/T/MAC,
B/MAC, and MAC, developed in these culture conditionsin Table 1, the majority (76%) of the colonies with
lymphoid potential contained only B cell precursors (B) strongly suggests that the restricted patterns of lineage
development within the colonies reflect the presence ofand displayed no T cell or myeloid/erythroid potential.
Although all colonies contained a visible macrophage precursors with distinct potentials.
component when picked, many did not have detectable
macrophage precursors suggesting a complete matura- Gene Expression Analysis of the
Myeloid/Lymphoid Coloniestion of this lineage during colony growth under these
conditions. A subpopulation of lymphoid colonies did Based on precursor analysis, the previous set of experi-
ments demonstrated differences in the developmentalretain some macrophage precursor potential as ob-
served by the growth of secondary macrophage colo- potential of the myeloid/lymphoid colonies. While this
approach has the capacity of measuring rare popula-nies in the replated cultures. Of these, approximately
half also had B cell potential (B/MAC, 11%), whereas tions from multiple lineages, it can be somewhat mis-
leading if the lineage of interest has matured beyondthe remainder displayed the unique combination of B
cell/T cell potential (B/T/MAC, 13%). No colonies with the clonogenic stage. Thus, to further characterize the
developmental potential of the myeloid/lymphoid popu-T cell/macrophage (T/MAC)-, B cell/T cell (B/T)-, or T
cell (T)-restricted potential were detected. lations, individual day 8±10 colonies were analyzed in
parallel for gene expression pattern and lineage poten-When grown in the presence of IL-7, KL, IL-11, Epo,
and S-17, the majority of the 39 colonies with lymphoid tial. As shown in Figure 5, all the colonies displaying
either B/T/MAC/MAST/ERY, B/T/MAC, B/MAC, or B lin-potential analyzed contained only B lineage precursors,
as in the previous conditions. These additional cytokines eage potential expressed c-fms, a macrophage-specific
gene that encodes the receptor to M-CSF. Expressiondid increase the frequency of the B/MAC colonies but
B/T/MAC-Restricted Fetal Precursor
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in establishing that they do not contain cells of these
lineages. The lack of b major globin expression in the
B/T/MAC/MAST/ERY colony suggests that the erythroid
lineage is immature and has not yet undergone signifi-
cant hemoglobinization.
Clonal Analysis of the Myeloid/Lymphoid Colonies
The previous data suggest the existence of a precursor
with B cell, T cell, and macrophage potential, assuming
that the individual colonies are clonal. To address this
issue, we used a retroviral marking method to track
the origin of the lineages within these colonies. Freshly
isolated AA4.11/FcR1 cells were infected with N2, a re-
combinant retrovirus that expresses the neor gene, by
coculture with the virus-producing cell line. After infec-
tion, the fetal liver cells and virus-producing cells were
harvested by trypsinization and seeded at low density
in methylcellulose in the presence of IL-7, KL, IL-11,
Epo, Leptin, S-17, and G418. Individual G418-resistant
myeloid/lymphoid colonies were picked and B cells, T
cells, macrophages, and in some experiments mast cells
generated from them. An aliquot of each colony was
also assayed for myeloid and erythroid potential. Out of
54 individual neor colonies, 12 (22%) displayed B/T/MAC
potential, whereas 3 (5%) contained the multilineage
combination of erythroid, mast cell, macrophage, B, and
T lymphocyte precursors (B/T/MAC/MAST/ERY). As the
number of cells available to characterize the retroviral
integration sites was limited, a sensitive inverse PCR
method was utilized for this analysis. With this approach,
a small fragment of DNA adjacent to the 39 LTR of the
retrovirus was amplified, visualized on an agarose gel,
and subsequently sequenced (Figure 6A). A total of 13
colonies were analyzed, 11 with B/T/MAC potential and
2 with B/T/MAC/MAST/ERY potential. A common band
in the B cell, T cell, and macrophage lineages from eight
individual B/T/MAC colonies was successfully ampli-
fied. Sequence analysis indicated that the commonFigure 4. Analysis of B Cell and T cell Precursor Content of Individ-
ual Colonies band in each of the lineages from an individual colony
(A) IgH rearrangements of cells from colonies with either B/T/MAC/ was identical, demonstrating a common integration site.
MAST/ERY (#15) or B/T/MAC (#16) developmental potential. (B) In addition, the sequence analysis clearly showed dis-
FACS analysis of fetal thymi repopulated with cells from colonies tinct integration sites between different colonies. These
#15 and #16.
results demonstrate that the B cell, T cell, and macro-
phage lineages within a colony develop from a common
precursor. Representative analysis of four of these colo-of c-fms in all colonies is consistent with the fact that
nies is presented in Figures 6B and 6C. Similarly, B cells,they all contained initially a macrophage component,
T cells, and macrophages from one of the colonies withincluding those that only displayed B cell and no macro-
B/T/MAC/MAST/ERY potential, and B cells, T cells, mac-phage precursor activity upon replating (depicted as
rophages, and mast cells from the second of these colo-B colonies in Figure 5). The transcription factor Ikaros
nies were found to contain the same retroviral integra-(Georgopoulos et al., 1994) and the Ig heavy chain Cm
tion site, demonstrating that these colonies were alsogenes were also expressed in all colonies, confirming
clonal (data not shown). More restricted bands were alsothe functional studies that demonstrated that they con-
observed in this analysis, possibly reflecting secondarytained either B cell and T cell or only B cell precursors.
infection during colony growth of the AA4.11/FcgR1 pre-In contrast to the broad expression pattern of these
cursors, as virus-producing cells were harvested andgenes, GATA-1, a transcription factor specific to the
included in the methylcellulose with fetal liver cells.mast cell, erythroid, and megakaryocyte lineages (Orkin,
Thus, the MAC/B cell±restricted band observed in col-1992), was only detected in the colonies that contained
ony 2 and 3 and the T cell±restricted band in colony 4precursors for these lineages (B/T/MAC/MAST/ERY).
of Figure 6B may reflect further commitment to a B/MACThe absence of GATA-1 expression in the B/T/MAC,
B/MAC, and B colonies confirms the precursor analysis or T cell precursor during colony growth.
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Figure 5. Gene Expression Analysis of Myeloid/Lymphoid Colonies
Aliquots of colonies were amplified by polyA1 PCR and hybridized with the 39 fragment of the cDNA of the indicated genes. Colonies with
functional B/T/MAC/MAST/ERY, B/T/MAC, B/MAC, or B developmental potential were analyzed. Controls include unfractionated day 13 fetal
liver cells, day 15 fetal thymocytes, bone marrow cells, macrophage colonies from fetal liver (MAC), a pre-B cell line (70Z/3), mast cell colonies
from fetal liver (MAST), erythroid colonies from bone marrow (ERY), and the S-17 stromal cells (S-17).
Discussion and T cell potential but lacking the capacity to generate
detectable myeloid or erythroid progeny. These appar-
ent differences between fetal and adult lymphopoiesisThe findings presented in this report demonstrate the
existence of a precursor with B cell, T cell, and macro- could reflect fundamental differences in the develop-
ment of the two systems or the fact that the adult B/T/phage potential in the early stages of fetal liver develop-
ment. This B/T/MAC precursor may represent one of MAC and B/MAC and the fetal CLP have not yet been
identified. Future experiments will distinguish betweenthe earliest lymphoid restriction points within the fetal
hematopoietic system. These findings extend the obser- these possibilities.
The full developmental potential of the B/T/MAC pre-vations of Cumano et al. (1992) and demonstrate that,
in addition to the B cell lineage, the fetal T cell lineage cursor may extend beyond B cells, T cells, and macro-
phages, as there is mounting evidence that suggestsalso develops in close association with the macrophage
lineage. While we did not detect any T/MAC-restricted that NK cells and possibly a subpopulation of dendritic
cells are closely related to the lymphoid lineages (Laniercells, the recent study of Kawamoto et al. (1997) sug-
gests that this type of precursor may exist as well. Taken et al., 1992; Rodewald et al., 1992; Ardavin et al., 1993;
Sanchez et al., 1994; Wu et al., 1996; Carlyle et al., 1997;together, these observations provide strong evidence that
the fetal lymphoid system develops from a lymphoid/ Wu et al., 1997). Preliminary studies have indicated that
the myeloid/lymphoid colonies do contain NK1.11 cells,macrophage-restricted precursor.
Although the evidence for a lymphoid/macrophage- suggesting that the B/T/MAC precursor does have NK
potential (unpublished data). Functional analysis will berestricted precursor in the fetal system is solid, the rela-
tionship between these lineages in the adult lymphoid required to determine if these cells are indeed NK cells.
The dendritic cell potential of the B/T/MAC remains to besystem is less well defined. A number of different studies
using adult bone marrow or spleen populations have determined. A precursor with B/T/MAC/NK/DC potential
could represent the cell that seeds the fetal thymic rudi-demonstrated ªlineage switchingº from B cells to macro-
phages suggesting a close relationship between these ment, as studies have demonstrated the presence of
these lineages in this developing organ. Our currentlineages in the adult (Davidson et al., 1988; Klinken et
al., 1988; Borzillo et al., 1990; Principato et al., 1990; studies aimed at isolating and characterizing early thy-
mic precursor populations will determine if the equiva-Borrello and Phipps, 1996). However, the equivalent of
the B/MAC or the B/T/MAC has not yet been identified lent of the fetal liver B/T/MAC exists in the fetal thymus.
Analysis of the growth factor requirements of the B/T/in the bone marrow. The concept of an adult lymphoid/
macrophage-restricted precursor has been challenged MAC precursors revealed a potential role for leptin in
early lymphopoiesis. The fact that leptin did not increaseby the recent studies of Kondo et al. (1997), which de-
scribed a common lymphoid precursor (CLP) with B cell the number of myeloid/lymphoid colonies suggests that
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Figure 6. Clonal Analysis of the B Cell, T Cell,
and Macrophage Precursors in the Myeloid/
Lymphoid Colonies
(A) Scheme of the inverse PCR strategy used
for identification of the retroviral integration
sites in the different lineages. 1, 2, 3, and
4 refer to the oligonucleotides used in this
analysis. (B) Ethidium bromide±stained gels
of the PCR products from macrophages, B
cells, and T cells generated from four individ-
ual G418-resistant colonies. Arrows show
common bands in the three different lineages.
(C) Sequences of the cellular DNA found in
the common bands shown in 6B. Sequence
from macrophage, B cell, and T cell popula-
tions derived from the colonies 1, 2, and 4
are shown. TaqI restriction site sequences
are indicated by boxes.
it does not stimulate the development of B/T/MAC pre- The findings from the in vitro and in vivo experiments
indicate important differences between the AA4.11 andcursor but rather promotes the development/survival of
lymphoid and myeloid precursors within these colonies. the AA4.11/FcgR1 fetal liver fractions. Specifically, ex-
pression of FcgR1 together with AA4.1 appears to defineOur findings are consistent with previous studies that
have demonstrated that leptin can promote the growth a subpopulation enriched for precursors committed to
lymphoid and macrophage development. These findingsof myeloid, erythroid, and lymphoid precursors in culture
and that the leptin receptor is expressed in various he- together with previous studies showing FcgR1 expres-
sion on fetal liver B cell precursors (Carlsson et al., 1995)matopoietic and lymphoid precursor populations (Bau-
mann et al., 1996; Bennett et al., 1996; Gainsford et al., and fetal thymic T cell and NK cell precursors (Rodewald
et al., 1992; Hattori et al., 1996) suggest that this family1996; Mikhail et al., 1997). In addition, it has been shown
that db/db mutant mice that express a truncated splice of receptors could play some role in early lymphoid
development. While the expression data are consistentvariant of the leptin receptor have reduced numbers of
early B cell precursors as well as reduced numbers of with this interpretation, analysis of FcR g chain knockout
mice that do not express FcgRIII did not reveal anylymphoid and myeloid colony forming cells compared
to wild-type animals (Bennett et al., 1996; Chen et al., significant alterations in adult lymphoid development
(Takai et al., 1994). Thus, the function of FcgR1 on these1996; Lee et al., 1996). While leptin did enhance the
potential of the fetal liver-derived myeloid/lymphoid col- subpopulations of lymphoid precursors remains to be
determined.onies, preliminary studies demonstrate only low levels
of leptin receptor in these colonies (unpublished data). In In conclusion, we have identified a precursor with the
potential to generate B cells, T cells, and macrophagescontrast, S-17 stromal cells appear to express abundant
levels of the receptor, suggesting that the effects of in a subpopulation of day 13 fetal liver defined by the
expression of AA4.1 and FcgRII/III. The developmentalleptin could be indirect. Future studies will be required
to determine if this is indeed the case. potential of this precursor defines an early restriction
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and different combinations of growth factors. Recombinant IL-7point during the establishment of the lymphoid system
(Upstate Biotechnology, Inc) and leptin (PrepoTech) were used atthat links the fetal B cell and T cell lineages at a stage
16 ng/ml and 250 ng/ml, respectively. Different batches of leptinbeyond the multipotential stem cell. Access to the colo-
were used with similar results. For developmental analysis, individ-
nies generated by this precursor will provide an opportu- ual colonies were picked following 8 to 10 days of culture and
nity to further define the molecular events involved in fractionated as follows: 20% of the cells for the myeloid/erythroid
precursor assay, 10% of the cells for the B cell precursor assay,the development of these lymphoid lineages.
and the remaining 70% of the cells for the T cell precursors assay.
In some experiments, 10% of the cells of a colony were used forExperimental Procedures
gene expression analysis and 60% of the cells assayed for T cell
precursors in FTOC.Mice
C57BL/6 mice (Taconic) were paired late in the afternoon and the
B Cell Assay and Amplification of IgH Genefemales checked the next morning for the presence of a vaginal
Rearrangements from Genomic DNAplug (day 0). Pregnant mice were sacrificed 13 days later, the uteri
Freshly isolated fetal liver fractions or cells from myeloid/lymphoidremoved, and the livers harvested from the fetuses. Fetal thymi were
colonies were cultured on irradiated S-17 stromal cells in IMDMobtained from day 15 timed mated outbred Swiss/Webster mice
supplemented with 10% FCS and 3% IL-7 CM from NIH 3T3 cells(Taconic). CB17 SCID mice were obtained from a breeding colony
transfected with a vector expressing IL-7 (Rolink et al., 1991). Follow-maintained in the animal care facility of the National Jewish Medical
ing 1 to 2 weeks of culture, the cells were harvested and the cellularand Research Center. Before transplantation, SCID mice were pre-
DNA analyzed for Ig heavy chain gene rearrangements by PCR astreated with an intraperitoneal injection of 50 ml of reconstituted
previously described (Carlsson et al., 1995). Hybridizations wereanti-asiolo GM1 (Wako Pure Chemical Industries) and sublethally
performed with a XbaI-HindIII germline JH4 probe. The VH PCR oligo-irradiated with 300 rads from a 137Cs source. Anti-asiolo GM1 treat-
nucleotide also primed between the JH3 and JH4 germline genesments were repeated on days 5 and 11 following injection of the
giving rise to a band of approximately the same size as a VDJH4fetal liver cells via the tail vein.
rearrangement. This band hybridized to the JH4 containing probe
and was used as an internal control for the PCR reaction and hybrid-CFU-S Assay
ization.Different fetal liver cell populations were transplanted via tail vein
injection into irradiated (920 rads) C57BL/6 recipient mice. Nine days
Fetal Thymic Organ Culturesfollowing transplantation, the mice were sacrificed, their spleens
Thymus lobes were dissected from outbred Swiss/Webster fetusesfixed in Bouins solution, and the colonies scored under a dissecting
at day 15 of gestation and seeded with fetal liver cells as previouslymicroscope.
described (Carlsson et al., 1995). After 2 to 3 weeks of culture, the
thymic lobes were harvested, the cells dissociated, blocked withCell Sorting, Staining, and Antibodies
unlabeled 2.4G2, and stained with appropriate antibodies. Cells ofFetal liver cells were stained as previously described (Carlsson et
fetal liver origin were identified by the presence of the Thy 1.2 alleleal., 1995). Between 40±70 3 106 stained cells were sorted on an
and could be distinguished from cells of fetal thymi origin that ex-Epics Coulter 741 or a Coulter Elite cell sorter. Reanalysis of the
press Thy 1.1.sorted AA4.11 and AA4.11/FcgR1 cells revealed a purity of .90%.
For analysis of reconstituted mice or cells from fetal thymic organ
Gene Expressioncultures, single cell suspensions were preincubated with unlabeled
Gene expression was determined using the polyA1 PCR method2.4G2 antibody to prevent nonspecific binding to the FcR. Antibod-
described by Brady et al. (1990). Reverse transcription, tailing, andies used for staining included biotinylated EH144.19 (H-2Kb), biotin-
PCR procedures were performed as described, with the exceptionylated 34.5.8 (H-2Kd), biotinylated 536.7212 (CD8), FITC-labeled
that the (dT)-x oligonucleotide was shortened to 59-CATCTCGAGGGOX-7 (Thy-1.1, Pharmingen), FITC-labeled 53-2.1 (Thy-1.2, Phar-
CCGC(T)24-39. Amplified products from the PCR reaction were sepa-mingen), FITC anti-IgM (Southern Biotechnology Associates, Inc),
rated on agarose gel and transferred to a Z-probe GT membraneFITC-labeled 145-2C11 (CD3), FITC-labeled M1/70 (Mac-1, Phar-
(Biorad). The resulting blots were hybridized with 32P randomlymingen), FITC-RB6-8C5 (Gr-1, Pharmingen), PE-labeled H57-597
primed cDNA fragments corresponding to the 39 region of the genes.(ab TCR, Pharmingen), PE-labeled GL4 (gd TCR, Pharmingen), PE-
labeled H129.19 (CD4, Pharmingen), and PE-TER-119 (Pharmingen).
Infection of Precursors and Analysis of Retroviral Integration
Freshly isolated d13 FL AA4.11/FcR1 cells were infected by over-Clonal Assays
The colony assay for detection of myeloid and erythroid precursors night coculture with g-irradiated GPE86-N2 producing cells in the
presence of IL-7, KL, IL-11, Epo, Leptin, polybrene (4 mg/ml), andwas carried out in Petri dishes in 1 ml cultures containing 1% methyl-
cellulose in Iscoves Modified Dulbecco's Medium (IMDM, GIBCO), 10% FCS in IMDM. The following day, cells were harvested by
trypsinization and plated at low density in methylcellulose in the10% plasma-derived serum (PDS; Antech, TX) and the following
mixture of growth factors: interleukin-1 ([IL-1] 1000 units/ml), in- presence of IL-7, KL, IL-11, Epo, Leptin, g-irradiated S-17 stromal
cells, and G418 (1 mg/ml). After 8 to 10 days of culture, individualterleukin-3 ([IL-3] 1% conditioned medium), kit ligand ([KL] 1% con-
ditioned medium), interleukin-11 ([IL-11] 35 ng/ml), erythropoietin myeloid/lymphoid colonies were picked and fractionated to grow
different cell populations. Macrophages were grown on tissue cul-([Epo] 2 units/ml), macrophage-colony stimulating factor ([M-CSF]
100 units/ml), granulocyte-macrophage-colony stimulating factor ture dishes in IMDM containing 30% L cell CM, IL-3, and 10% FCS.
After 2 days, the cells were passaged into 30% L cell CM, 10%([GM-CSF] 20 units/ml), and thrombopoietin ([TPO] 5 ng/ml). Recom-
binant human IL-1a was kindly provided by Hoffmann-La Roche FCS, and IMDM. The cells were subsequently maintained and pas-
saged into the same media for 2 to 3 weeks to obtain a homogeneous(Nutley, NJ), IL-3 was provided by conditioned medium (CM) of X63
Ag8±653 myeloma cells transfected with a vector expressing IL-3 monolayer of macrophages. B cells were grown on irradiated S-17
in the presence of IL-7. The cultures were passaged 2 to 3 times.(Karasuyama and Melchers, 1988), and KL was provided by CM of
a cell line transfected with a vector expressing KL kindly provided Mast cells were grown in bacterial grade dishes in IMDM media
containing KL, IL-3, and 10% FCS. The suspension cells were fre-by Genetics Institute. Recombinant M-CSF, IL-11, and GM-CSF,
TPO, were purchased from R&D Systems. All factors were tested quently passaged to eliminate adherent cells and to generate a
homogeneous population of mast cells. T cells were harvested fromindividually to give optimal growth. All single lineage colonies were
scored at days 7±9, while the multilineage colonies were scored at reconstituted fetal thymi.
Genomic DNA was digested overnight with TaqI and then phenol/days 9±14.
Myeloid/lymphoid colonies were grown from freshly isolated fetal chloroform extracted and precipitated. An aliquot of diluted DNA
was ligated, and the reaction was stopped by phenol/chloroformliver cells in 1 ml cultures containing 1% methylcellulose in IMDM,
10% fetal calf serum (FCS), g-irradiated S-17 stromal cells (105/ml), extraction. Primer sequences used in the first PCR are 59-AGGACCT
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GCTTACCACA-39 (oligonucleotide 1) and 59-CTGTTCCTTGGGAG Davidson, W., Pierce, J., Rudikoff, S., and Morse, H. (1988). Relation-
ship between B cell and myeloid differentiation. Studies with a BGGT-39 (oligonucleotide 2). The samples were denatured (958C, 1
min), annealed (408C, 1 min), and elongated (728C, 1 min) for 35 lymphocyte progenitor line, HAFTL-1. J. Exp. Med. 168, 389±407.
cycles. Aliquots of 1/10 of these reactions were further amplified Gainsford, T., Willson, T.A., Metcalf, D., Handman, E., McFarlane,
with the following nested primers: 59-GCTGGTGATATTGTTGAGTCA C.A., Nicola, N.A., Alexander, W.S., and Hilton, D.J. (1996). Leptin
AAAG-39 (oligonucleotide 3) and 59-TTGGGAGGGTCTCCTCT can induce proliferation, differentiation, and functional activation of
GAG-39 (oligonucleotide 4). The samples were denatured (958C, 1 hemopoietic cells. Proc. Natl. Acad. Sci. USA 93, 14564±14568.
min), annealed (488C, 1 min), and elongated (728C, 2 min) for 35 Galy, A., Travis, M., Cen, D., and Chen, B. (1995). Human T, B,
cycles. The resulting PCR products were separated on a 1.5% aga- natural killer, and dendritic cells arise from a common bone marrow
rose gel, and DNA from common bands were purified with QIAEX progenitor cell subset. Immunity 3, 459±473.
II resin (Qiagen) and sequenced using oligonucleotide 4 as primer.
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